Research & Development: Page 78
-
PharmaVoice Team/PharmaVoice
A Growing Community of Good Citizens, Part II
SPECIAL FEATURE # CITIZENS PHILANTHROPY HAS BECOME PART AND PARCEL OF CORPORATE LIFE IN MANY NATIONS.FOR SOME COMPANIES IN THE LIFESCIENCES, HOWEVER,THERE IS A GROWING DESIRE TO TAKE THAT ONE STEP FURTHERWITH GRASSROOTSVOLUNTEERISM. Last month, PharmaVOICE told its readers about some of the remar...
By Kim Ribbink • May 27, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Michelle GadsdenWilliams is VP and Global Head of Diversity and Inclusion at Novartis Pharma AG.She was one of 75 women honored for her accomplishments at the 2005 Tribute to Women in Industry (TWIN) Gala, Harvard’s 2008 BMF Businesswoman of the Year, the Rainbow Push Coalition’s Bridge Builder A...
By PharmaVoice Team • May 27, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
PharmaTrax
As patients live longer and are increasingly diagnosed with chronic and often debilitating ailments, pharmaceutical decisionmakers find themselves examining ways to adapt their organizations to address the resulting healthcare needs in both human and business terms. According to the report, the p...
By PharmaVoice Team • May 27, 2008 -
PharmaVoice Team/PharmaVoice
17th Annual Partnerships with CROs
17th Annual Partnerships with CROs Hundreds of clinical development and outsourcing professionals gathered in Las Vegas for the annual conference. Attendees were treated to a packed lineup of workshops, tracks, and keynote addresses covering the hot topics in clinical research and development. .E...
By PharmaVoice Team • April 30, 2008 -
PharmaVoice Team/PharmaVoice
Dr. Bob Sliskovic — A Quest for Discovery
keeps scientists like Dr. Sliskovic in search of the next great compound. “The anticipation of success is an extreme ly powerful stimulant,” he says. “I’ve watched scientists receive the cruelest blows in terms of having a pet compound die, but the next morning they would be back and raring to go...
By Kim Ribbink • April 30, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
ONTHE CALENDAR May 1516 13th Annual Pharmaceutical &Biotech Licensing &Deal Making Summit Hyatt Regency NewBrunswick,New Brunswick,N.J. For more information, contact Cheryl KahanRadhuber,Strategic Research Institute, at 2129670095, email [email protected], or visit srinstitut...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES eDrugSearch has unveiled the eDrugSearch.com Community, a social network for Americans seeking safe, lowcost prescrip tion medications online. The Health 2.0 community comple ments eDrugSearch’s specialized search engine for prescr...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Immune Tolerance Institute (ITI), a new nonprofit company, is bringing economies of scale to translational and critical path science to build partnerships with the pharmaceutical and biotech industries, and accelerate the development of new ...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Expansion in size and number of clinical trials. The increase in clinical trials has been prompted by regulators seeking more extensive study data to validate drug safety. Greater numbers of postmarketing Phase IV studies and a rising level of drug development activity have also contributed to th...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
The Fourth Hurdle: The Call for Pharmacoeconomic Data
Managed MARKETS What began as a movement by government payers in other parts of the world is now making its mark here in the United States. Pharmacoeconomics — the scientific discipline that compares the value of one pharmaceutical drug to another to assess its value and costeffectiveness — has b...
By Denise Myshko • April 29, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Study Coordinator A is an early adopter of technology on the cutting edge of the next generation processes who is always eager to try something new. Study Coordinator B is a risk averse, technological laggard who subscribes to the “if it isn’t broken, don’t fix it” mantra. Herein lies one of the ...
By Gil Kampfer • April 29, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
SOURCE:CEGEDIMDENDRITE,BEDMINSTER,N.J. DTC ALERT Shift to Physician Offices, Online Programs Cegedim Dendrite’s annual survey indicates DTC marketing is moving away from traditional mass media promotion. According to the survey, almost twothirds of marketers want to see more spending on emerging ...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Every month our goal is to feature thought leaders who have the ability to change the course of the industry. This month we exceeded this goal in spades. We are pleased to pay homage to the HBA’s 95 Rising Stars, some of the industry’s brightest and most talented individuals. These executive wome...
By Taren Grom • April 29, 2008 -
PharmaVoice Team/PharmaVoice
From Scorpion to Cancer
MOTHER NATURE BUILT IT, MAN IS IMPROVING IT. TransMolecular’s 131 ITM601 is a synthetic version of a peptide from the venom of scorpions combined with a radioactive iodine. In Phase I/II trials to treat glioma,a deadly form of brain cancer, the product can deliver a targeted dose of radiation to ...
By Denise Myshko • April 25, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
84 F e b ru a r y 200 3 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ProscapeTechnologies has anew Internet tool to make facetoface selling more effective. Proscape.Net provides mobile sales organizations a common technolo gy platform to exchange, update, c...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Pharmaceutical companies wanting to gain an edge in managedcare markets can turn to PharmaStrat Inc. for comprehensive market research services.The recently launched company was founded by Philip J. Patrick, a pharmaceutical execu...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
February 10,2003,Park Hyatt San Francisco — San Francisco European Regulatory Affairs: An InDepth Review of Registration Procedures in the European Union This Drug Information Association training course will cover the evolu tion of the registration systems available for approval of products sinc...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Survey Shows One Third of Americans USE ANTIBIOTICS INAPPROPRIATELY A survey conducted by Harris Interactive has revealed that one out of three Americans mistakenly believes antibiotics are effective in treating viruses such as cold and flu and takes these drugs to fight these viruses. The survey...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
When launching a newproduct, marketers tend to focus on core audiences such as the physician and the patient, and on the clinical aspects of the drug, highlighting safety and clinical effectiveness. These factors are essential to a successful launch, but there are two additional fac tors that are...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Three, ...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
Walt Woltosz — Quantum Leap
Walt Woltosz is using his experience with simulation software in the aerospace industry to try to transform the way pharmaceutical companies approach data gathering and research, and he’s proving that it just might take a rocket scientist to get the industry on track. WHAT DOES THE PHARMACEUTICAL...
By Kim Ribbink • April 24, 2008 -
PharmaVoice Team/PharmaVoice
Crossing the EDC Chasm
By Dr. Paul Bleicher The emergence of comprehensive eCDM solutions that can seamlessly link together traditional and electronic data management may be the technology that sponsors are still seeking. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE, PAUL BLEICHER, M.D., PH.D., FOUNDER, CHAIRMAN, AND CHI...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEB-BASED APPLICATIONS, SITES, AND TECHNOLOGIES CLINPHONE Unveils New Website ClinPhone has redesigned its Website, clinphone.com, to give it more functionality and a portal style. The site contains more product information than the previous site, including details of ClinPhone...
By PharmaVoice Team • April 22, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARE-RELATED PRODUCTS, SERVICES, AND COMPANIES DIA AND CENTERWATCH TEAM UP to Disseminate Clinical Research Information This collaborative agreement establishes an ongoing process to jointly deliver, throughout the world, a more complete continuum of practical and valuable information f...
By PharmaVoice Team • April 22, 2008 -
PharmaVoice Team/PharmaVoice
Anthony Tebbutt — A global Perspective
A Global PERSPECTIVE BY KIM RIBBINK With a diverse professional background, spanning several functions as well as several countries, Anthony Gordon Tebbutt is working to propel UCB Pharma Inc. into a billion-dollar company. A COMPANY WITH A WORLDWIDE PRESENCE AND A PEOPLEORIENTED APPROACH TO BUSI...
By Kim Ribbink • April 22, 2008
Previous
